Rhazinilam a structurally relatively simple tetracyclic natural product exerts interesting anticancer activities in vitro, which are difficult to reproduce in vivo. Based on the findings accumulated during the synthetic efforts and on the known metabolic sensitivity towards oxidation and acids a modified structural analogue of rhazinilam is proposed. A novel convergent approach towards the heterocyclic biaryl unit is described. The key sequence for the construction of 7 is the Mukaiyama crossed aldol reaction followed by the Staudinger reaction. Using known N-alkylation procedures the introduction of the side chains onto the 3-pyrrolin-2-one intermediate 2 needed for the construction of the tetracycle could not be achieved.
Introduction
(R)-(-)-Rhazinilam 1 and some of its congeners manifest a remarkable in vitro activity on the tubulin-microtubules equilibrium involved in the formation of mitotic spindle. [1] [2] [3] [4] These tetracyclic compounds were identified as promising targets for developing of a new generation of anticancer agents. The scientific challenge of this relatively simple natural product is disclosing and explaining in structural terms its activity. Transferring the knowledge from in vitro studies to in vivo experiments has proved to be quasi impossible. 5 The combination of the findings on the chemical reactivity, with the well-known sensitivity of rhazinilam towards oxidative metabolic transformations 6 was used as a guideline for proposing and designing novel rhazinilam analogues. The retrosynthetic approach chosen is conceived so as to avoid the notorious sensitivity of non-stabilized pyrroles towards oxidation and/or acid conditions avoiding protecting groups as much as possible. However, two syntheses published during the preparation
The synthesis of these acrylates started with -butyrolactone 14 which was converted into the Weinreb amide 15 according to the procedure described by Fukuda et al. 25, 26 However, the activated acrylate 22 could be obtained from -butyrolactone 14 in seven steps and 31% overall yield.
N-alkylation of 4-(2-nitrophenyl)-1H-pyrrol-2(5H)-one 2
In the literature only a few examples of N-alkylation of tetramates have been reported. 34, 35 Thus, Jones and Bates 34 accomplished the alkylation of NH-3-pyrrolin-2-one by two procedures. Nmethylated 4-O-methyltetramate 24a was obtained from 3-pyrrolin-2-one 23a using a strong base such as n-BuLi at low temperature (Scheme 5).
Scheme 5.
Reported N-alkylation of O-metyl tetramate 23a using n-BuLi. 34 However, the most effective reported N-alkylation procedure used phase-transfer (PT) conditions for promoting N-1 deprotonation and alkyl iodides or benzyl bromides as electrophiles (Scheme 6). Under these conditions double alkylation products 25 were often coisolated in minor amounts. A more recent systematic study of the reaction of 4-O-methyl tetramate was reported by Jones and Patience. 35 The amount of N-1, C-5 or multiple alkylations could be influenced by the stoichiometry of the reagents. Di-and trialkyl derivatives were obtained using 10 mol equivalents of base and alkyl halide. In many cases increasingly large excess of these reagents and/or longer reaction times led to extensive decomposition of 3-pyrrolin-2-one. In some cases even O-alkylated by-products were isolated. However, the normal sequence of deprotonation of tetramates was brought to light.
Based on the encouraging results reported in the literature, we focused our attention on the Nalkylation with alkyl iodide 20 of 3-pyrrolin-2-one 2 quantitatively prepared from compound 8 by deprotection using TFA. Despite numerous efforts varying the approach and the reaction parameter the N-alkylation of 3-pyrrolin-2-one 2 using olefin 20 could not be achieved in our hands (Table 1) . Often starting material could be re-isolated or degradation of 3-pyrrolin-2-one was observed as evidenced by the poor mass-balance after work-up and purification. Using nBuLi as a strong base at low temperatures and then warming the solution to room temperature led to recovery of the iodide 20 whereas the 3-pyrrolin-2-one 2 was degraded (Entry 1). Using different variants of the phase transfer alkylation did not lead to product formation either. Under these milder conditions both starting materials could be partially recovered (Entry 2 -4). Using strong bases like potassium hexamethylsilazane or sodium hydride in THF or in DMF did not allow detection of product formation (Entry 5 and 6 for KHMDS and 7 to 9 for NaH). 
Conclusions
The synthesis of an advanced precursor for the planned synthesis of the rhazinilam analogue could be achieved using the tandem process Mukaiyama aldol condensation -Staudinger cyclisation. The pyrrolidinone 7 was transformed in two steps into the 2-silyloxypyrrole 9. This electron-rich pyrrole was transformed in two steps, reaction with the aldehyde followed by oxidation, into compound 11. Further transformation of this advanced intermediate was hampered by its sensitivity to acids and to oxygen. As an alternative we studied the N-alkylation of the 3-pyrrolin-2-one 2. This process is attractive because the product of the N-alkylation could contain all the atoms and the functionality needed for the formation of the ring D via Michael addition. In this process the substituent for the elaboration of ring B could be introduced simultaneously. We report the synthesis of this building block. The side chain needed for the construction of the ring B could be introduced. Under the conditions reported in the literature and under the conditions tested in our laboratory, the introduction of a side chain by nucleophilic Nalkylation could not be achieved. Further studies are required which will be reported in due time.
Experimental Section
General. Reactions employing air-and/or moisture-sensitive reagents and intermediates were carried out under nitrogen or argon using dry solvents. Thin layer chromatography TLC: The retention factor (R f ) quoted is rounded to the nearest 0.01. (4) . 15 To a stirred solution of LHMDS (1.0 M in THF, 100 mL, 100 mmol) in dry THF (30 mL) was added dropwise a solution of methyl acetate (6.17 g, 83.33 mmol) in dry THF (37 mL) at -78 °C and under argon. After 30 min at -78 °C, TMSCl (10.86 g, 100 mmol) was added dropwise over 20 min. The mixture was allowed to stir at -78 °C for 1.5 h. The solvent was removed in vacuo and the excess salts were precipitated by the addition of dry pentane (30 mL). After filtration through a plug of Celite and evaporation of solvent, the residue was purified by distillation (48-50 °C/45 mmHg) to afford 11.68 g of 4.
Yield: (96% ), 2.5 (Si-CH 3 ). Methyl 4-azido-3-hydroxy-3-(2-nitrophenyl)butanoate (6). 15 2-Azido-1-(2-nitrophenyl)-ethanone 3 (3.0 g, 14.55 mmol) was added portionwise to a stirred solution of ((1-methoxyvinyl)oxy)trimethylsilane 4 (6.39 g, 43.66 mmol) in dry CH 2 Cl 2 (60 mL) at -30 °C and under argon. A solution of freshly distilled TiCl 4 (0.84 mL, 7.28 mmol) in dry CH 2 Cl 2 (10 mL) was added dropwise over 15 min. The resulting mixture was stirred at -30 °C for 15 min and then allowed to reach -15 °C over a period of 30 min. The dark red solution was quenched with NaOH (2.0 M, 15 mL) and extracted with CHCl 3 (4 × 20 mL). The combined organic phases were washed with brine (30 mL), dried over MgSO 4 , filtered and concentrated. The residue was purified by flash chromatography on silica gel using CH 2 Cl 2 as eluent to afford 3.39 g of 6 as a clear, slightly yellowish oil which solidified on standing. The product was crystallised from Et 2 O/hexane to give pure 6 (3.10 g., 76% 
